Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
British Journal of Anaesthesia|August 23, 2023
'To see ourselves as others see us'Jennifer M Hunter, John NormanBritish Journal of Anaesthesia|April 17, 2025
Developing novel drugs to reverse neuromuscular block: do we need them?Jennifer M Hunter, Manfred BlobnerBritish Journal of Anaesthesia|June 28, 2023
Educating anaesthetists on neuromuscular monitoring: the challenges continueJan Poelaert, Jennifer M HunterBritish Journal of Anaesthesia|December 22, 2023
Under-dosing and over-dosing of neuromuscular blocking drugs and reversal agents: beware of the risksJennifer M Hunter, Manfred BlobnerDrugs & Aging|January 22, 2003
Selecting neuromuscular-blocking drugs for elderly patientsTristan M Cope, Jennifer M HunterBritish Journal of Anaesthesia|January 3, 2024
Is adamgammadex the brother of sugammadex or the next generation of reversal agent?Jennifer M Hunter, J Robert SneydBritish Journal of Anaesthesia|October 1, 2022
How robust are the STRONGER and STIL-STRONGER studies?Manfred Blobner, Jennifer M Hunter, Kurt UlmFertility and Sterility|February 7, 2022
Intracytoplasmic sperm injection 30 years on: too much of a good thing?Robert John NormanPharmaceutical Patent Analyst|June 28, 2016
Pharmaceutical patent law: the Canadian perspectiveLivia Aumand, John NormanPharmaceutical Patent Analyst|December 12, 2017
Canada's Supreme Court abolishes 'promise of the patent'John Norman, Alex GloorPageof 5